Evidence map›Paper›PMID 41724829›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026

Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease.

Min Uk Jang, Min Seong Kim, Jihyun Hwang, Hyung Seok Kim, Sang Won Jo, Sung Jae Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Comment on - Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease: clinical caveats beyond a one-year claims analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  2. Reconsidering fracture risk reduction in Parkinson's disease: limitations of claims-based inference.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Min Uk Jang *NV Brain Neurology Clinic, Seoul, Republic of Korea.
Min Seong Kim *Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.
Jihyun HwangThe George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Hyung Seok KimDepartment of Orthopedic Surgery, Hanyang University Hospital, Seoul, Republic of Korea.
Sang Won JoDepartment of Radiology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea. cjinas@gmail.com.
Sung Jae KimDepartment of Orthopedic Surgery, College of Medicine, Hanyang University, Seoul, Republic of Korea. sung1383@hanyang.ac.kr.ORCID http://orcid.org/0000-0003-4785-8154

Funding

Ministry of Science and ICT, South Korea 24A0102L1National Research Foundation of Korea NRF-2022R1C1C1011649
6 · The paper itself

Abstract

purposePatients with Parkinson's disease, often accompanied by osteoporosis, have a higher risk of osteoporotic fractures. However, a large cohort study assessing the preventive effect of bisphosphonates for osteoporotic fracture on patients with Parkinson's disease is scarce. 

methodsThis retrospective cohort study included nearly whole population of South Korea during 2002 to 2018 from the national patient database of Korea National Health Insurance Service. Of 608,202 patients with Parkinson's disease, a total of 7335 patients were selected for index regression model and 5806 patients were further selected for landmark model of 1 year after diagnosis of osteoporosis. Occurrence of osteoporotic fracture was set defined as outcome variable for both regression models.

resultsRegression analysis with a landmark model one year after the index diagnosis of osteoporosis showed that the use of bisphosphonates had a significant preventive effect on osteoporotic fractures (hazard ratio [HR] 0.83, 95% confidence interval [CI] 0.73-0.96, p = 0.012). In index regression model, higher age, larger waist circumference, smoking, and history of lymphoma were significant risk factors of osteoporotic fractures. Higher weight and higher physical activity score were significant preventative factors.

conclusionIn the regression analysis with landmark model with 5806 patients, higher age, heavy alcohol consumption, smoking, and history of solid tumor were significant risk factors of osteoporotic fractures. Higher weight was a significant preventative factor.

Indexed as

Bone Density Conservation AgentsDiphosphonatesOsteoporosisOsteoporotic FracturesParkinson DiseaseAgedAged, 80 and overDatabases, FactualDrug UtilizationFemaleHumansMaleMiddle AgedRepublic of KoreaRetrospective StudiesRisk FactorsBone Density Conservation AgentsDiphosphonatesBisphosphonate useFracture ratesParkinson’s disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.